Cargando…

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease

Kynurenine 3-monooxygenase (KMO) regulates the levels of neuroactive metabolites in the kynurenine pathway (KP), dysregulation of which is associated with Huntington’s disease (HD) pathogenesis. KMO inhibition leads to increased levels of neuroprotective relative to neurotoxic metabolites, and has b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bondulich, Marie Katrin, Fan, Yilan, Song, Yeojin, Giorgini, Flaviano, Bates, Gillian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943810/ https://www.ncbi.nlm.nih.gov/pubmed/33750843 http://dx.doi.org/10.1038/s41598-021-84858-7

Ejemplares similares

Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013)

A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics
por: Maddison, Daniel C., et al.
Publicado: (2020)

Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
por: Collier, Mary EW, et al.
Publicado: (2021)

Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
por: Swaih, Aisha M., et al.
Publicado: (2022)

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
por: Sathyasaikumar, Korrapati V., et al.
Publicado: (2022)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
por: Pido-Lopez, Jeffrey, et al.
Publicado: (2019)

Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease
por: Steinert, Joern R., et al.
Publicado: (2012)

A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
por: Zhang, Shaowei, et al.
Publicado: (2019)

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
por: Parrott, Jennifer M., et al.
Publicado: (2015)

Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Connecting the dots in Huntington's disease with protein interaction networks
por: Giorgini, Flaviano, et al.
Publicado: (2005)

Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2014)

Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014)

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
por: Lu, Yifei, et al.
Publicado: (2020)

Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019)

Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice
por: Imbeault, Sophie, et al.
Publicado: (2021)

Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
por: Mimasu, Shinya, et al.
Publicado: (2021)

Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
por: Pruccoli, Letizia, et al.
Publicado: (2021)

Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018)

Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
por: Hutchinson, Jonathan P., et al.
Publicado: (2017)

Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation
por: Lassiter, Randi, et al.
Publicado: (2021)

Kynurenines in CNS disease: regulation by inflammatory cytokines
por: Campbell, Brian M., et al.
Publicado: (2014)

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
por: Jin, Haojie, et al.
Publicado: (2015)

Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016)

Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity
por: Morita, Nanaka, et al.
Publicado: (2021)

Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers
por: Lai, Min-Hua, et al.
Publicado: (2021)

Protocatechuic acid prevents isoproterenol‐induced heart failure in mice by downregulating kynurenine‐3‐monooxygenase
por: Bai, Liyan, et al.
Publicado: (2023)

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington’s disease
por: Irvine, Elaine E., et al.
Publicado: (2019)

Glycation potentiates neurodegeneration in models of Huntington’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2016)

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
por: Rojewska, Ewelina, et al.
Publicado: (2018)

The Kynurenine 3-Monooxygenase Encoding Gene, BcKMO, Is Involved in the Growth, Development, and Pathogenicity of Botrytis cinerea
por: Zhang, Kang, et al.
Publicado: (2018)

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients
por: Oxenkrug, Gregory, et al.
Publicado: (2017)

Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase
por: Gotina, Lizaveta, et al.
Publicado: (2021)

Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington’s disease models
por: Smalley, Joshua L., et al.
Publicado: (2015)

Alkylglycerol Monooxygenase
por: Watschinger, Katrin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_getftlj2ufcfefhftavoa8mjkr